PILL ETF Holdings

Holdings

Symbol	Grade	Price % Change	Allocation
OGN	B	-1.50	4.31
MRK	B	-0.48	3.98
PFE	C	-0.12	3.97
ELAN	C	0.53	3.93
AXSM	D	0.32	3.89
PRGO	D	-0.23	3.81
LLY	C	-1.35	3.77
CTLT	D	-0.02	3.75
ITCI	C	-0.36	3.73
JAZZ	F	0.69	3.66
JNJ	D	0.40	3.60
RPRX	F	0.20	3.55
VTRS	D	0.68	3.52
ZTS	D	0.66	3.50
CORT	B	-0.77	3.21
BMY	F	-1.32	3.18
ARVN	F	4.14	1.91
AMPH	F	-0.90	1.72
TARS	B	0.47	1.57
SAVA	D	-2.98	1.54
PBH	D	-2.27	1.13
EYPT	F	-0.77	1.11
PCRX	D	3.04	1.11
LBPH	C	-2.48	0.95
HRMY	F	-0.57	0.94
INVA	B	0.47	0.89
COLL	D	-1.80	0.78
AMRX	B	0.00	0.76
LGND	B	0.35	0.75
LQDA	D	5.12	0.75
SUPN	F	0.77	0.69
PLRX	F	3.84	0.52
ANIP	C	0.00	0.51
RVNC	F	-4.67	0.43
EOLS	D	1.74	0.39
OCUL	D	-1.27	0.33
TBPH	C	-3.05	0.31
XERS	F	2.78	0.30
FULC	D	-3.64	0.22
MRNS	F	-1.13	0.05

Represented by ETF Holdings

Keywords: Biopharmaceutical Pain Pharmaceutical Medicine Pharmaceutical Products S&P 500 Alzheimer's Disease Animal Health Drugs Neuroscience Biotechnology Depression Diabetes Disease Hypertension Life Sciences Medication Pharmacology Suspension Antibiotics

Industries: Biotechnology Drug Manufacturers - Specialty & Generic Drug Manufacturers - Major Drug Manufacturers - General Medical Distribution

Recent News for Direxion Daily Pharmaceutical & Medical Bull 3X Shares ETF & its Holdings

Date	Stock	Title
May 16	PFE	2 Top Growth Stocks Down 24% and 50% to Buy With $100
May 16	LLY	Roche Shares Climb After Weight-Loss Drug Shows Efficacy in Early-Stage Trial
May 16	LLY	Eli Lilly once-weekly insulin hits main goal in late-stage trials
May 16	LLY	These 2 No-Brainer Growth Stocks Are Breaking New Ground
May 16	LLY	UPDATE 2-Lilly's weekly insulin as effective as daily doses in studies
May 16	LLY	With Once-a-Week Dosing, Insulin Efsitora Alfa Delivers A1C Reduction and Safety Profile Consistent with Daily Insulin
May 16	ARVN	Arvinas and Pfizer Announce Updated Clinical Data from Phase 1b Trial of Vepdegestrant in Combination with Palbociclib (IBRANCE®)
May 16	PFE	Arvinas and Pfizer Announce Updated Clinical Data from Phase 1b Trial of Vepdegestrant in Combination with Palbociclib (IBRANCE®)
May 16	PFE	Pfizer agrees to pay up to $250M to settle Zantac cancer lawsuits - report
May 16	LGND	Insider Sale: President & Chief Operating Officer Matthew Korenberg Sells Shares of Ligand ...
May 16	PBH	Prestige Consumer Healthcare Inc (PBH) (Q4 2024) Earnings Call Transcript Highlights: ...
May 16	EOLS	Director David Gill Sells 10,361 Shares of Evolus Inc (EOLS)
May 16	EOLS	Director Vikram Malik Sells 28,000 Shares of Evolus Inc (EOLS)
May 16	PFE	UPDATE 1-Pfizer offers up to $250 mln to settle Zantac cancer lawsuits, FT reports
May 16	PFE	Pfizer offers up to $250 million to settle Zantac cancer lawsuits, FT reports
May 16	MRK	Merck & Co., Inc. (MRK) BofA Securities 2024 Health Care Conference (Transcript)
May 16	BMY	Bristol Myers Squibb’s CAR T Cell Therapy Breyanzi Approved by the U.S. Food and Drug Administration for Relapsed or Refractory Follicular Lymphoma
May 15	BMY	Bristol-Myers Squibb Company (BMY) Bank of America Global Healthcare Conference 2024 Transcript
May 15	LLY	Dow Jones Futures: Dow, S&P 500, Nasdaq Hit Highs, Nvidia Leads 12 New Buys; What To Do Now
May 15	BMY	Tudor Investment's top buys and sells in Q1

The investment seeks daily investment results, before fees and expenses, of 300% of the daily performance of the S&P Pharmaceuticals Select Industry Index. The fund invests at least 80% of its net assets in financial instruments, such as swap agreements, securities of the index, and ETFs that track the index and other financial instruments that provide daily leveraged exposure to the index or to ETFs that track the index. The index is a modified equal-weighted index that is designed to measure performance of the stocks comprising the S&P Total Market Index that are classified in the GICS pharmaceuticals sub-industry. The fund is non-diversified.
Exchange Traded Funds

ETF Components for PILL - Direxion Daily Pharmaceutical & Medical Bull 3X Shares ETF